Sleep and type 2 diabetes mellitus

Practical Diabetes

Volumn 33, Issue 1, 2016, Pages 23-26

  Brady, Emer M ^a   Hall, Andrew P ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM SLEEP DISORDER; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; SLEEP; SLEEP DEPRIVATION; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SLEEP TIME;

EID: 84979008622     PISSN: 20472897     EISSN: 20472900     Source Type: Journal    
DOI: 10.1002/pdi.1993     Document Type: Article

References (46)

1. Kryger MH, et al. Principles and practice of sleep medicine, 4th edn. Elsevier Saunders, 2004.
2. Van Cauter E, et al. Sleep, awakenings, and insulin-like growth factor-1 modulate the growth hormone (GH) secretory response to GH-releasing hormone. J Clin Endocrinol Metab 1992;74:1451–9.
3. Spiegel K, et al. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354(9188):1435–9.
4. Van Cauter E, et al. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest 1991;88:934–42.
5. Spiegel K, et al. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels and increased hunger and appetite. Ann Intern Med 2004;141:846–50.
6. Rechtschaffen A, Kales A (eds). A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. National Institutes of Health (USA). Publication no. 204, Neurological Information Network, 1968.
7. National Sleep Foundation. Sleep Health. 2015 http://sleepfoundation.org/media-center/press-release/national-sleep-foundation-recommends-new-sleep-times.
8. Gangwisch JE, et al. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep 2007;30:1667–73.
9. Yaggi K, et al. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006;29:657–61.
10. Theorell-Haglöw J, et al. Sleep duration and central obesity in women – differences between short sleepers and long sleepers. Sleep Med 2012;13:1079–85.
11. Cappuccio FP, et al. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010;33:585–92.
12. Cappuccio FP, et al. Sleep deprivation predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 2011;32:1484–92.
13. Leng Y, et al. Sleep duration and risk of fatal and nonfatal stroke. A prospective study and meta-analysis. Neurology 2015;84:1072–9.
14. Kendzerska T, et al. Obstructive sleep apnea and incident diabetes. A historical cohort study. Am J Respir Crit Care Med 2014;190:218–25.
15. Monahan K. Role of obstructive sleep apnoea in cardiovascular disease. Curr Opin Cardiol 2011;26:541–7.
16. Wilcox I, et al. ‘Syndrome Z’: the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998;53(Suppl 3):S25–8.
17. Sharma SK, Sreenivas V. Are metabolic syndrome, obstructive sleep apnoea and syndrome Z sequential? A hypothesis. Indian J Med Res 2010;131:455–8.
18. Chaput JP, et al. Association of sleep duration with type 2 diabetes and impaired glucose tolerance. Diabetelogia 2007;50:2298–304.
19. Knutson KL, et al. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006;166:1768–74.
20. Ayas NT, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003;26:380–4.
21. Mallon L, et al. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12 year follow-up study of middle-aged population. Diabetes Care 2005;28:2762–7.
22. Gangwicsch JE, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 2006;47:833–9.
23. Cappuccio FP, et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension. The Whitehall Study. Hypertension 2007;50:694–701.
24. Lung CM, et al. Energy expenditure during sleep, sleep deprivation and sleep following sleep deprivation in adult humans. J Physiol 2011;589:235–44.
25. Uehli K, et al. Sleep quality and the risk of work injury: A Swiss case-control study. J Sleep Res 2014;23:545–53.
26. Uehli K, et al. Sleep problems and work injury types: A study of 180 patients in a Swiss emergency department. Swiss Med Wkly 2013;143:w13902.
27. Gold DR, et al. Rotating shift work, sleep, and accidents related to sleepiness in hospital nurses. Am J Public Health 1992;82:1011–4.
28. Vennelle M, et al. Sleepiness and sleep-related accidents in commercial bus drivers. Sleep Breath 2010;14:39–42.
29. Reutrakul S, Van Cauter E. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci 2014;1311:151–73.
30. Bergman RN. Lilly Lecture 1989: toward physiological understanding of glucose tolerance – minimal model approach. Diabetes 1989;38:1512–27.
31. Lucassen EA, et al. Interacting epidemics? Sleep curtailment, insulin resistance, and obesity. Ann N Y Acad Sci 2012;1264:110–34.
32. Bosy-Westphal A, et al. Influence of partial sleep deprivation on energy balance and insulin sensitivity in healthy women. Obes Facts 2008;1(5):266–73.
33. Liu A, et al. Habitual shortened sleep and insulin resistance: an independent relationship in obese individuals. Metabolism 2013;62:1553–6.
34. Donga E, et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab 2010;95:2963–8.
35. Calvin AD, et al. Effects of experimental sleep restriction on caloric intake and activity energy expenditure. Chest 2013;144:79–86.
36. Kolovou GD, et al. The prevalence of metabolic syndrome in various populations. Am J Med Sci 2007;333(6):362–71.
37. Desroches S, Lamarche B. The evolving definitions and increasing prevalence of the metabolic syndrome. Appl Physiol Nutr Metab 2007;32:23–32.
38. XI B, et al. Short sleep duration predicts risk of metabolic syndrome: a systematic review and meta-analysis. Sleep Med Rev 2014;18:293–7.
39. Shan Z, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2015;38:529–37.
40. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976;4:97–110.
41. Merikanto I, et al. Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int 2013;30:470–7.
42. Reutrakul S, et al. Chronotype is independently associated with glycemic control in type 2 diabete. Diabetes Care 2013;36:2523–9.
43. Vetter C, et al. Mismatch of sleep and work timing and risk of type 2 diabetes. Diabetes Care 2015;38:1707–13.
44. Wilson SJ, et al. British Association of Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharm 2010;24:1577–601.
45. Guest JF, et al. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K. Diabetes Care 2014;37:1263–71.
46. The IDF Consensus statement on sleep apnoea and type 2 diabetes. www.idf.org/sleep-apnoea-and-type-2-diabetes.